BRA
BMY icon

Bender Robert & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Bender Robert & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-27,442
Closed -$1.23M – 51
2024
Q1 		$1.49M Sell
27,442
-250
-0.9% -$12.7K 0.35% 27
2023
Q4 		$1.42M Sell
27,692
-5
-0% -$262 0.36% 27
2023
Q3 		$1.61M Sell
27,697
-600
-2% -$36.8K 0.47% 28
2023
Q2 		$1.81M Buy
28,297
+410
+1% +$27.5K 0.5% 27
2023
Q1 		$1.93M Sell
27,887
-60
-0.2% -$4.23K 0.6% 27
2022
Q4 		$2.01M Hold
27,947
– – 0.75% 27
2022
Q3 		$1.99M Buy
27,947
+2,885
+12% +$209K 0.77% 27
2022
Q2 		$1.93M Sell
25,062
-300
-1% -$22.8K 0.74% 27
2022
Q1 		$1.85M Buy
25,362
+9,937
+64% +$667K 0.53% 28
2021
Q4 		$913K Hold
15,425
– – 0.26% 30
2021
Q3 		$913K Buy
15,425
+66
+0.4% +$4.35K 0.26% 32
2021
Q2 		$1.03M Buy
15,359
+1,580
+11% +$103K 0.29% 31
2021
Q1 		$870K Buy
13,779
+851
+7% +$52.9K 0.28% 33
2020
Q4 		$802K Buy
12,928
+1
+0% +$61 0.26% 32
2020
Q3 		$779K Buy
12,927
+201
+2% +$12.1K 0.28% 32
2020
Q2 		$748K Buy
12,726
+2,560
+25% +$153K 0.3% 32
2020
Q1 		$567K Sell
10,166
-39
-0.4% -$2.38K 0.3% 34
2019
Q4 		$655K Sell
10,205
-160
-2% -$9.16K 0.3% 34
2019
Q3 		$526K Sell
10,365
-467
-4% -$21.9K 0.26% 35
2019
Q2 		$491K Sell
10,832
-839
-7% -$39.1K 0.23% 36
2019
Q1 		$557K Sell
11,671
-100
-0.8% -$4.98K 0.27% 34
2018
Q4 		$612K Sell
11,771
-409
-3% -$22K 0.35% 34
2018
Q3 		$756K Hold
12,180
– – 0.34% 32
2018
Q2 		$674K Sell
12,180
-389
-3% -$21K 0.35% 32
2018
Q1 		$795K Sell
12,569
-110
-0.9% -$7.08K 0.44% 29
2017
Q4 		$777K Sell
12,679
-324
-2% -$20.3K 0.43% 27
2017
Q3 		$829K Buy
13,003
+490
+4% +$28.6K 0.48% 27
2017
Q2 		$697K Sell
12,513
-508
-4% -$27.6K 0.43% 28
2017
Q1 		$708K Sell
13,021
-1,050
-7% -$57.6K 0.46% 28
2016
Q4 		$822K Buy
14,071
+291
+2% +$15.9K 0.58% 26
2016
Q3 		$743K Buy
13,780
+364
+3% +$23.4K 0.49% 26
2016
Q2 		$987K Sell
13,416
-489
-4% -$34.6K 0.7% 25
2016
Q1 		$888K Sell
13,905
-386
-3% -$24.3K 0.6% 27
2015
Q4 		$983K Buy
14,291
+1,131
+9% +$74.7K 0.63% 25
2015
Q3 		$779K Buy
13,160
+1,270
+11% +$80.6K 0.53% 26
2015
Q2 		$791K Buy
11,890
+257
+2% +$16.9K 0.47% 27
2015
Q1 		$750K Buy
11,633
+1,057
+10% +$66.2K 0.44% 29
2014
Q4 		$624K Buy
10,576
+509
+5% +$28.7K 0.41% 29
2014
Q3 		$515K Sell
10,067
-170
-2% -$8.49K 0.36% 33
2014
Q2 		$497K Sell
10,237
-200
-2% -$9.86K 0.35% 34
2014
Q1 		$22.5K Sell
10,437
-99
-0.9% -$5.27K 15.11% 1
2013
Q4 		$560K Sell
10,536
-245
-2% -$12.5K 0.42% 32
2013
Q3 		$499K Buy
10,781
+126
+1% +$5.53K 0.39% 34
2013
Q2 		$476K Buy
+10,655
New +$463K 0.41% 33

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bender Robert & Associates's BMY Position: Q2 2024 in Review

Bender Robert & Associates sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 27,442 shares — an estimated $1.23M sold.

Bender Robert & Associates first reported a position in BMY in Q2 2013 and held it in 44 quarters. The position peaked at $2.01M in Q4 2022. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Bender Robert & Associates reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Bender Robert & Associates sold 27,442 Bristol-Myers Squibb shares in Q2 2024, an estimated $1.23M.
  • Bender Robert & Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 44 quarters.
  • Bender Robert & Associates's Bristol-Myers Squibb position peaked at $2.01M in Q4 2022.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Bender Robert & Associates's 13F filing for Q2 2024, filed 30 Jul 2024.